Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
This research study is evaluating a behavioral intervention designed to help people with advanced lung cancer manage dyspnea (i.e., breathlessness or shortness-of-breath).
Checked against the public recordLast updated Feb 27, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Behavioral: Dyspnea Intervention; Other: Usual Care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * A diagnosis of either NSCLC, SCLC, or mesothelioma, not being treated with curative intent * Self-reported shortness of breath (a score of 2 or greater on the Modified Medical Research Council Dyspnea Scale) * Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 2 (symptomatic and in bed \<50% of day) * The ability to read and respond to questions English * Primary cancer care at the Massachusetts General Hospital (MGH) Cancer Center or Dana-Farber Cancer Institute (DFCI) * Age \>18 years Exclusion Criteria: * Cognitive or psychiatric conditions prohibiting study consent or participation. * A treating clinician who reports that the patient is inappropriate for the study
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Massachusetts General HospitalBoston, Massachusetts
- Dana Farber Cancer InstituteBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 27, 2025. Always confirm current availability with the study team.